SUPERIOR EFFICACY OF COMBINATION PHARMACOTHERAPY FOR TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY

被引：0
|
作者：
Fraser, M. O. [1 ]
Lloyd, J. C. [2 ]
Le, N. [2 ]
Wiener, J. S. [2 ]
Dolber, P. C. [3 ]
机构：
[1] Duke Univ, Med Ctr, Inst Med Res, Durham VAMC, Durham, NC USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Duke Univ, Med Ctr, Durham VAMC, Durham, NC USA
来源：
INTERNATIONAL UROGYNECOLOGY JOURNAL | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
OP 020
引用
收藏
页码：S95 / S96
页数：2
相关论文
共 50 条
  • [31] OnabotulinumtoxinA in Refractory Neurogenic Detrusor Overactivity
    Dasgupta, Prokar
    EUROPEAN UROLOGY, 2011, 60 (04) : 751 - 752
  • [32] Botulinum Toxin in Neurogenic Detrusor Overactivity
    Levi D'Ancona, Carlos Arturo
    Ferreira, Ruiter Silva
    Rassi, Mauricio Carneiro
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2012, 16 (03) : 139 - 143
  • [33] Efficacy and Safety of Transdermal and Oral Oxybutynin in Children With Neurogenic Detrusor Overactivity
    Cartwright, Patrick C.
    Coplen, Douglas E.
    Kogan, Barry A.
    Volinn, Weining
    Finan, Eileen
    Hoel, Gary
    JOURNAL OF UROLOGY, 2009, 182 (04): : 1548 - 1554
  • [34] Efficacy of onabotulinumtoxinA in neurogenic detrusor overactivity is independent of concomitant anticholinergic use
    Sievert, K. D.
    Heesakkers, J.
    Ginsberg, D.
    Cruz, F.
    Jenkins, B.
    Thompson, C.
    Lam, W.
    Haag-Molkenteller, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E461 - U8
  • [35] COMBINATION PHARMACOTHERAPY FOR TREATMENT OF NEUROGENIC BLADDER
    Lloyd, Jessica C.
    Ngoc-Bich Le
    Wiener, John S.
    Dolber, Paul C.
    Fraser, Matthew O.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 197 - 198
  • [36] Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison
    Cruz, Francisco
    Danchenko, Natalya
    Fahrbach, Kyle
    Freitag, Andreas
    Tarpey, Jialu
    Whalen, John
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 200 - 207
  • [37] Editorial Comment to Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder
    Sekido, Noritoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (10) : 905 - 905
  • [38] Sustained Clinical Efficacy after Repeat Intradetrusor Botulinum Toxin Type A in the Treatment of Neurogenic Detrusor Overactivity
    Png, Keng Siang
    Toh, Khai-Lee
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (02) : 152 - 153
  • [39] Efficacy of peripheral lidocaine application (neural therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
    Tamam, Yusuf
    Ozdemir, Hasan Huseyin
    Gedik, Abdullah
    Tamam, Cuneyt
    Nazlikul, Huseyin
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (07) : 1832 - 1838
  • [40] Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis
    Yuan, Hejia
    Cui, Yuanshan
    Wu, Jitao
    Peng, Peng
    Sun, Xujie
    Gao, Zhenli
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2017, 21 (01) : 53 - 61
12345